Osteoarthritis Trial, Recruiting NCT07449468 Sponsor: Poznan University of Medical Sciences Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07449468
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 75 years or older
  • People who are scheduled for a planned (non-emergency), first-time total hip replacement surgery
  • People whose surgery is planned to use spinal anaesthesia (numbing from the waist down)
  • People classified as having a moderate level of pre-existing health conditions, as assessed by their medical team (known as ASA physical status II or III — confirm with trial site)
  • People who are able to sign a written consent form agreeing to take part
  • People who are able to communicate clearly and reliably rate their pain on a numbered scale (0–10)
  • People expected to stay in hospital for at least 72 hours (3 days) after surgery

Who may not be able to join:

  • People who already have delirium, acute psychosis, or an active major mental health condition
  • People with severe dementia, or who are unable to give informed consent to participate
  • People with serious hearing or vision problems that would make it difficult to complete standard confusion assessments during the study
  • People for whom spinal or regional anaesthesia is not medically appropriate — for example, due to blood clotting problems, infection near the injection site, or allergy to local anaesthetic medicines
  • People who already have nerve or neurological problems in the leg being operated on that would interfere with assessments
  • People who have been regularly taking high doses of opioid pain medicines (more than 30 mg morphine-equivalent per day for more than 2 weeks before surgery)
  • People with severely reduced kidney function (confirm with trial site)
  • People with severe liver problems
  • People who have taken part in another interventional clinical trial within the past 30 days
  • People with any other condition that the trial investigators believe could interfere with safe participation or following the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +48 61 8320122

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Poznan University of Medical Sciences
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
1 May 2027

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Incidence of postoperative delirium

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov